On a corporate action affecting depositary receipt of JPMorgan Chase Bank, N.A. representing ordinary share of Dr. Reddy’s Laboratories Limited (RDY)

On October 4, 2024, Dr. Reddy’s Laboratories Limited announced a stock split at a ratio of 5:1 to be effective after the markets close on November 4, 2024. Trading is expected to begin on a stock split-adjusted basis on November 5, 2024. For more details, please, refer to the company’s website.

ITS Ltd. will publish separate notices on the procedures undertaken by ITS Ltd. to process this corporate action outlining how trading in these qualified investments will be carried out.